Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adults Overt Hepatic Encephalopathy is caused by cirrhosis of the liver As complications from chronic liver disease increase, recognizing OHE is critical ...
(CORRECTS INFO ABOUT TSX AND DOLLAR CLOSING FIGURES) Equities in Canada's largest centre got to ...
As every investor would know, not every swing hits the sweet spot. But you want to avoid the really big losses like the...